SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS) | stella

Learn Data Labs For Researchers Find trials matched to me

Learn Data Labs For Researchers Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS) | stella

Back to Lupus Erythematosus, Systemic trials

Active, not recruiting

Plain-English translation of NCT05141201 on ClinicalTrials.gov ↗ · Source last updated June 2026 · How we translate trials

Read our Lupus Erythematosus, Systemic research guide →

Trial locations(47 sites)

Japan

Research Site, Aichi

Research Site, Akita

Research Site, Aomori

Research Site, Chiba

Research Site, Ehime

Key details

Sponsor

AstraZeneca

Enrollment target

~1,620 participants

Started

December 2021

Primary completion

March 2027

Last updated on clinicaltrials.gov in June 2026.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov